Companies: 10,795·Total market cap: $144.5T
Applied Molecular Transport Inc.

Applied Molecular Transport Inc.

AMTINASDAQHealthcare
$0.26
$-0.01(-3.13%)
Market Cap$11006287
P/E Ratio
52W High$0.84
52W Low$0.1343
Overview

Applied Molecular Transport Inc. (AMTI) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

amti · pe ratio · data through Dec 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Applied Molecular Transport Inc. (AMTI) measures how much investors pay for each dollar of the company's trailing earnings. AMTI's current PE ratio of N/A is calculated by dividing its stock price of $0.26 by its TTM earnings per share of -$3.23.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31

Forward P/E
N/A
FY2025 est. EPS $-0.69
Based on 0 analysts
EPS (TTM)
-$3.23
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Applied Molecular Transport Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2018 – 2022 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Applied Molecular Transport Inc.
Applied Molecular Transport Inc.You
AMTI
$11MN/A-$3.23
Allena Pharmaceuticals, Inc.
Allena Pharmaceuticals, Inc.
ALNA
$0MN/A-$1.03
Apexigen, Inc.
Apexigen, Inc.
APGN
$10MN/A-$1.59
Boston Therapeutics, Inc.
Boston Therapeutics, Inc.
BTHE
$0MN/A-$0.01
Channel Therapeutics Corporation
Channel Therapeutics Corporation
CHRO
$9MN/A-$2.30
Gelesis Holdings, Inc.
Gelesis Holdings, Inc.
GLS
$12MN/A-$0.79
IMV Inc.
IMV Inc.
IMVIF
$0MN/A-$4.37

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-12-31Latest
FY2022
$-3.23
2021-12-31
FY2021
$-2.56
2020-12-31
FY2020
$-2.82
2019-12-31
FY2019
$-1.31
2018-12-31
FY2018
$-1.70

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Applied Molecular Transport Inc. (AMTI) measures how much investors pay for each dollar of the company's trailing earnings. AMTI's current PE ratio of N/A is calculated by dividing its stock price of $0.26 by its TTM earnings per share of -$3.23.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.26 ÷ -$3.23 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

AMTI pe ratio · 6 questions

AMTI's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.26 and TTM EPS of -$3.23. Data sourced from Financial Modeling Prep via AMTI's SEC 10-K and 10-Q filings.

AMTI PE ratioWhat is AMTI PE ratioCurrent PE ratio of AMTIAMTI PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Applied Molecular Transport Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09